rom the 1940s to the present, approximately 49% of all medicines approved by the
WHO are composed of active substances of natural origin or direct derivatives thereof.
About 75% of the medicines authorized by the WHO to counteract the direct and
indirect effects induced by bacteria, parasites and viruses (cytokine storms, toxins and
others) are of natural origin; highlighting the fact that 100% of the natural active
principles investigated, developed and used to control and cure bacterial, parasitic and
viral infections with almost 100% success correspond to metabolites present in foods
of vegan origin used by animals, "intuitively", in their natural environment to control
diseases caused by these same pathogens. Beyond that, the diet profiles of people in
Africa, North America, South America, Asia, Australia, and Eastern, Western, Northern,
and Southern Europe have been found to differ markedly. The differences in the diets
and in the composition of the nutrients that the people of the different regions ingest
are directly related to the level, degree and incidence in the presence and progression
of cancer, autoimmune diseases, diabetes, hormonal alterations and increased
susceptibility to contract infections and the development of symptoms, alterations and
the progression of the disease to serious, critical or fatal stages. This fact motivated
our team of scientists to focus on studies, starting in 1997, on the relationship that
exists between changes in feeding behavior adopted by wild animals, from the
moment in which the alterations caused by infections caused by viruses, parasites and
bacteria, with the effectiveness that changes in diet are caused in the control and cure
of the pathologies presented. We selected coronaviruses because, for approximately a
decade, we verified and received information on the recurrence of infections and
deaths caused by these pathogens in animals used in preclinical research in our
laboratory and others around the world. Since that date, we have conducted dozens of
investigations in the field of theoretical chemistry, high-throughput screening,
preclinical and clinical trials on the ability of families of active compounds present in
plants to prevent, control, treat and cure many diseases and also the pathological
alterations caused by parasites, bacteria and viruses in animals and man. These studies
culminated in the registration of a significant number of products that have shown
great effectiveness against the pathological processes for which they were developed.
When the "COVID-19" pandemic arrived, the experience accumulated over decades
allowed us to quickly extrapolate and correlate the knowledge acquired, during all that
time, towards the behavior that animals that fall ill with coronavirus follow and the
consequent correlation of these findings with we could expect in humans to become
infected with this type of virus. This reasoning was done avoiding any supposition, or
theory, about the transformation of this virus in a laboratory because, in addition to
the fact that this is not relevant to us, we know that pathogen modifications are
generally carried out by scientists to anticipate mutations of the viruses, bacteria and
others in nature in order to find cures for infections. Simultaneously, an analysis was
carried out on the evolution and application of the protocols recommended by the
WHO for the control and treatment of COVID-19, from the beginning of the pandemic
to the present; demonstrating that the most effective protocols for the control,
treatment and cure of patients affected by the Sar-CoV-2